نتائج البحث

安徽省2020--2023年脊髓灰质炎疫苗疑似预防接种异常反应监测分析.

• Authors : 胡文怡¹; 孟凡亚² ; 王斌冰²

• Source: Modern Preventive Medicine. 2024, Vol. 51 Issue 21, p3996-4001. 6p.

تفاصيل العنوان

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

• Authors : Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; Viroclinics Biosciences B.V.

• Source: A First-in-human, Phase 1, Randomized, Observer-blind, Controlled Study to Assess the Safety and Immunogenicity of Novel Live Attenuated Type 1 and Type 3 Oral

تفاصيل العنوان

Progress Toward Poliomyelitis Eradication - Afghanistan, January 2023-September 2024.

• Authors : Hardy CM; Rathee M; Chaudhury S

Subjects: Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/prevention & control ; Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/epidemiology ; Disease Eradication*

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Dec 12; Vol. 73 (49), pp. 1129-1134. Date of Electronic Publication: 2024 Dec 12.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

• Authors : Bio Farma, Indonesia

• Source: A Phase 1/2, Randomized, Observer-Blind, Active-Controlled, Age De-escalation, Dose Combination Ranging Study to Assess the Safety and Immunogenicity of Co-administered Novel Live Attenuated Trivalent

تفاصيل العنوان

Progress Toward Poliomyelitis Eradication -- Pakistan, January 2023-June 2024.

• Authors : Mbaeyi, Chukwuma¹ ; ul Haq, Anwaar²; Safdar, Rana Muhammad²

Subjects: *POLIO; *POLIOVIRUS; *SEROTYPES

• Source: MMWR: Morbidity & Mortality Weekly Report. 9/12/2024, Vol. 73 Issue 36, p788-792. 5p.

تفاصيل العنوان

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

• Authors : Bill and Melinda Gates Foundation; PT Bio Farma; Centers for Disease Control and Prevention

• Source: A Phase 2, Randomized, Observer-blind, Controlled, Age De-escalation, Dosage Escalation Study to Assess Safety and Immunogenicity of a Novel Live Attenuated Type 1 Oral

تفاصيل العنوان

Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)

• Source: A Phase 3 Randomized, Open-Label, Clinical Trial to Study the Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of V260 and Inactivated

تفاصيل العنوان

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa

• Source: Immune Response to Pertussis After Vaccination With a Tdap-IPV Booster Vaccine in Children in the Republic of South Africa: Effect of Homologous and Heterologous Pertussis Vaccination Priming

تفاصيل العنوان

Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers

• Source: A Study to Evaluate the Immunogenicity and Safety of Sequential Vaccination Among Infants With Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains

تفاصيل العنوان

Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023.

• Authors : Geiger K; Stehling-Ariza T; Bigouette JP

Subjects: Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/epidemiology ; Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/prevention & control ; Disease Eradication*

• Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 May 16; Vol. 73 (19), pp. 441-446. Date of Electronic Publication: 2024 May 16.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان